Chakraborty, R., Kastritis, E., Huart, A., Jaccard, A., Landau, H., Iida, S., Motorna, O., Mollee, P., Ishida, T., Kawano, Y., Bhutani, M., D'Souza, A., Cowan, A., Hoffman, J., Talati, C., Rosenberg, T., Motte-Mohs, R. L., Wang, F., Hoffman, D., Fei, M., Arriola, E., Yu, J., Kumar, S., Dispenzieri, A., Palladini, G., Sanchorawala, V. (2025). Phase 1/2 dose escalation and expansion study of etentamig in patients with relapsed or refractory light chain amyloidosis. Blood. https://doi.org/10.1182/blood-2025-692